Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Pullan = Game Changer

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Dec 16, 2021 4:50am

209 Views

Post# 34235596

RE:Pullan = Game Changer

Excellent move!

The management has finally realized that they need help. Too me it's a sign of strength and that they have matured.

Bringing Linda Pullan inboard tells me that

a) it's for real
b) the deal represent significant value
c) Linda Pullan brings street cred like R+F did (she should have been involved there too...)
d) the deal is not too far away

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec